Published 3 years ago

Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

Summary by Medical Dialogues

New Delhi: Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to USD 3.10 billion to jointly develop and market an experimental cancer...

0 Articles

All

Left

Center

Right

Medical Dialogues

Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

New Delhi: Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to USD 3.10 billion to jointly develop and market an experimental cancer...

3 years ago·New Delhi, India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated3 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

0 Articles

0 Articles

Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics